SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-05-045820
Filing Date
2005-09-27
Accepted
2005-09-27 07:13:04
Documents
2
Period of Report
2005-09-27

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 5681
2 EX-24 ex-24.htm EX-24 5930
  Complete submission text file 0001104659-05-045820.txt   13446
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878
SIC: 2834 Pharmaceutical Preparations

Mailing Address 132 PURDURE AVENUE KENGSINGTON CA 94708
Business Address 650-266-3717
BJERKHOLT ERIC (Reporting) CIK: 0001197350 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51531 | Film No.: 051104020